(Q46488511)

22 December 2017

title

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma (English)

1 reference

22 December 2017

0 references

1 reference

Yunhui Liu

1

1 reference

22 December 2017

Moneeb Ehtesham

2

1 reference

22 December 2017

Ken Samoto

3

1 reference

22 December 2017

Christopher J Wheeler

4

1 reference

22 December 2017

Reid C Thompson

5

1 reference

22 December 2017

Luis P Villarreal

6

1 reference

22 December 2017

Keith L Black

7

1 reference

22 December 2017

John S Yu

8

1 reference

22 December 2017

publication date

1 January 2002

1 reference

22 December 2017

published in

Cancer Gene Therapy

1 reference

22 December 2017

volume

9

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

9-15

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700399

exact match

0 references

cites work

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Acquisition of lymphokine-producing phenotype by CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Interleukin-12-based immunotherapy against rat 9L glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Induction of antitumor immunity using intercellular adhesion molecule 1 (ICAM-1) transfection in mouse glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Cellular and molecular mechanisms underlying IL-12-induced tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Direct Intratumoral Injection of an Adenovirus Expressing Interleukin-12 Induces Regression and Long-Lasting Immunity That Is Associated with Highly Localized Expression of Interleukin-12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

inferred from DOI database lookup

7 January 2021

based on heuristic

The JAM test. A simple assay for DNA fragmentation and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

inferred from DOI database lookup

7 January 2021

based on heuristic

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700399

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CGT.7700399

1 reference

22 December 2017

1 reference

22 December 2017